Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.

MLA

McNeel, Douglas G., et al. “Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients with Stage D0 Prostate Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 27, no. 25, Sept. 2009, pp. 4047–54. EBSCOhost, https://doi.org/10.1200/JCO.2008.19.9968.

APA

McNeel, D. G., Dunphy, E. J., Davies, J. G., Frye, T. P., Johnson, L. E., Staab, M. J., Horvath, D. L., Straus, J., Alberti, D., Marnocha, R., Liu, G., Eickhoff, J. C., & Wilding, G. (2009). Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 27(25), 4047–4054. https://doi.org/10.1200/JCO.2008.19.9968

Chicago

McNeel, Douglas G, Edward J Dunphy, James G Davies, Thomas P Frye, Laura E Johnson, Mary Jane Staab, Dorothea L Horvath, et al. 2009. “Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients with Stage D0 Prostate Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 27 (25): 4047–54. doi:10.1200/JCO.2008.19.9968.